MedPath

Reducing Racial Disparities in Severe Maternal Morbidity

Not Applicable
Recruiting
Conditions
Maternal Death
Interventions
Other: Doula Services
Other: Implementation of Maternal Safety Bundles
Registration Number
NCT04879797
Lead Sponsor
Tufts University
Brief Summary

There is a paucity of research examining the intersection of race, ethnicity, maternal safety bundles, doulas, and maternal outcomes in Black women at increased risk of severe maternal morbidity and mortality. The proposed mixed-methods study is the first systematic investigation of pregnancy complications and outcomes among Black women with whom maternal safety bundles are being implemented including racial disparities, hemorrhage, and hypertension. Additionally, through the analysis of secondary state level data, this study will examine perinatal care, maternal outcomes, and healthcare utilization of Black women at increased risk of severe maternal morbidity and mortality compared with non-Latino white women. Finally, through individual interviews with Black women and focus groups with obstetric health providers and doulas, the study will examine disparities and improve care by creating and disseminating a set of practice recommendations for maternity care for Black women at increased risk of morbidity and mortality.

Research has not yet examined the intersection of race/ethnicity, doulas, and quality improvement (QI) interventions, such as maternal safety bundles, on reducing SMM and mortality among non-Hispanic Black (NHB) women. The overall goal of this mixed-methods study is to use analysis of existing big data and the evaluation of two interventions to ultimately develop targeted recommendations for addressing these inequities. Our approach leverages multiple data sources to study maternal outcomes and access to care during the prenatal, birth, and postpartum periods in order to identify commonalities among women who experienced SMM and use those findings to create a risk profile of women who are more likely to experience SMM; examine the implementation of maternal safety bundles on SMM and MM outcomes for women up to 1 year postpartum (Intervention 1); gather in-depth data from obstetric care providers on factors that support or hinder safety bundle implementation (Intervention 1); and gather in-depth data from individual women and doulas on facilitators of barriers to the use of doulas to improve care and address inequities (Intervention 2).

Detailed Description

Background / Literature Review / Rationale for the study:

Black women experience stark disparities in pregnancy complications and outcomes compared to White women. Recognizing, tracking and understanding patterns of severe maternal morbidity (SMM) and associated inequities by race/ethnicity, along with developing and carrying out interventions to improve the quality of maternal care, are essential to reducing SMM and thereby maternal mortality. To date, there has been little research specifically aimed at understanding whether the maternal health inequities as experienced by Black women can be ameliorated through an integrated care model that includes engagement of providers in the planning and implementation of maternal safety bundles or engaging mothers in prenatal, birth and postpartum support from community doulas. The investigators will use the Health Impact Pyramid and CFIR Framework (Consolidated Framework for Implementation) to develop, implement and assess the effectiveness of such a system in reducing disparities in SMM and mortality. The data sources for this study will include state-level and hospital-specific discharge data collected as part of the Alliance for Innovation on Maternal Health (AIM) project and the Pregnancy to Early Life Longitudinal (PELL) data system, which focuses on population-level data needed to examine health inequities among racial and ethnic minorities in Massachusetts. In addition to these existing data sources, the investigators intend to establish a data collection tool to assess doula services as well as analyze qualitative data from interviews with Black women, and focus groups with obstetrical care providers and doulas to explore the effect of implementing safety bundles and incorporating doula-provided services into prenatal, birth and postpartum care.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
1538
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Doula ServicesDoula ServicesThe second intervention that this study evaluates is doula services. Investigators are evaluating doula services that are offered by two doula organizations at three hospitals. Investigators will provide top-up training to these doulas in order to provide some standardization and quality assurance of the services delivered. The training is developed and delivered by an obstetrician (Meadows) and doula (Gebel) and will take place among providers (staff associated with three chosen hospitals), patient navigators, and two doula groups, Birth Sisters and Accompany Doula Care, on factors that comprise the risk profile and how to offer targeted doula services to women who fit the risk profile. All sites will use standardized data instruments to evaluate the number of factors in the risk profile being met as well as standardized language and recruitment materials for mothers.
Maternal Safety Bundles ImplementationImplementation of Maternal Safety BundlesThe first intervention targets obstetric hemorrhage, severe hypertension and maternal health equity by implementing three relevant AIM bundles: Obstetric Hemorrhage, Severe Hypertension in Pregnancy, and Reduction of Peripartum Racial/Ethnic Disparities. The Perinatal Neonatal Quality Improvement Network (PNQIN) will facilitate this collaborative QI project and support participating hospitals by providing guidance, education, and technical assistance to hospitals to support implementation of bundles using the QI process. Implementation strategies are based on the Institute for Healthcare Improvement (IHI) improvement model and the AIM program implementation toolkit and have previously been used by PNQIN to implement the Obstetric Care for Women with Opioid Use Disorder AIM bundle in 22 hospitals, including the five hospitals for this study.
Primary Outcome Measures
NameTimeMethod
Patient experience - Respect6 -12 weeks postpartum

Measure through the mothers on respect index (MORi). Range is 14-84 with higher scores indicating more respect.

Severe maternal morbidity (SMM) 20At delivery

Severe maternal morbidity (SMM) includes unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health. Based on 20 ICD 10 codes as defined by the CDC.

Cesarean BirthAt delivery

The proportion of women with live births who have a C-section.

Severe maternal morbidity (SMM) 21At delivery

Severe maternal morbidity (SMM) includes unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health. Based on 21 ICD 10 codes as defined by the CDC.

Patient experience - Autonomy6 -12 weeks postpartum

Mothers autonomy in decision making (MADM). The range is 7- 42 with higher score indicating more opportunities to take an active role and lead decisions.

Secondary Outcome Measures
NameTimeMethod
Nulliparous, Term, Singleton, Vertex (NTSV) Cesarean Birth RateAt delivery

Of all NTSV births the proportion that result in C-section

Severe Maternal Morbidity among Hemorrhage CasesMonthly up to 6 months

Denominator: All mothers during their birth admission, excluding ectopics and miscarriages, meeting one of the following criteria:

* Presence of an Abruption, Previa or Antepartum hemorrhage diagnosis code

* Presence of transfusion procedure code without a sickle cell crisis diagnosis code

* Presence of a Postpartum hemorrhage diagnosis code Numerator: Among the denominator, all cases with any SMM code

Severe Maternal Morbidity (excluding cases with only a transfusion code) among Hemorrhage Cases.Monthly up to 6 months

Denominator: All mothers during their birth admission, excluding ectopics and miscarriages, meeting one of the following criteria:

* Presence of an Abruption, Previa or Antepartum hemorrhage diagnosis code

* Presence of transfusion procedure code without a sickle cell crisis diagnosis code

* Presence of a Postpartum hemorrhage diagnosis code Numerator: Among the denominator, all cases with any non-transfusion SMM code

Process Measure for Obstetric Hemorrhage - Quantified Blood Loss Measurement UtilizationMonthly up to 6 months

Report estimate in 10 percent increments (round up) In this quarter, what proportion of mothers had measurement of blood loss from birth through the recovery period using quantitative and cumulative techniques?

Process Measure for Obstetric Hemorrhage - Risk AssessmentMonthly up to 6 months

Report estimate in 10 percent increments (round up) At the end of this quarter, what cumulative proportion of mothers had a hemorrhage risk assessment with risk level assigned, performed at least once between admission and birth and shared among the team?

Structure Measure for Obstetric Hemorrhage - Patient, Family & Staff Support SystemMonthly up to 6 months

Report Completion Date Has your hospital developed OB specific resources and protocols to support patients, family and staff through major OB complications?

Structure Measure for Obstetric Hemorrhage - Hemorrhage CartMonthly up to 6 months

Report Completion Date Does your hospital have OB hemorrhage supplies readily available, typically in a cart or mobile box?

Structure Measure for Obstetric Hemorrhage - Unit Policy and ProcedureMonthly up to 6 months

Report Completion Date Does your hospital have an OB hemorrhage policy and procedure (reviewed and updated in the last 2-3 years) that provides a unit-standard approach using a stage-based management plan with checklists?

Structure Measure for Obstetric Hemorrhage - EHR IntegrationMonthly up to 6 months

Report Completion Date Were some of the recommended OB Hemorrhage bundle processes (i.e. order sets, tracking tools) integrated into your hospital's Electronic Health Record system?

Outcome Measure for Severe Hypertension/Preeclampsia - Severe Maternal Morbidity among Preeclampsia CasesMonthly up to 6 months

Denominator: All mothers during their birth admission, excluding ectopics and miscarriages, with one of the following diagnosis codes:

* Severe Preeclampsia

* Eclampsia

* Preeclampsia superimposed on pre-existing hypertension Numerator: Among the denominator, all cases with any non-transfusion SMM code

Process Measure for Severe Hypertension/Preeclampsia - Treatment of Severe HTNMonthly up to 6 months

Report N/D Denominator: Birthing patients with acute-onset severe hypertension that persists for 15 minutes or more, including those with preeclampsia, gestational or chronic hypertension Numerator: Among the denominator, birthing patients who were treated within 1 hour with IV Labetalol, IV Hydralazine, or PO Nifedipine. The 1 hour is measured from the first severe range BP reading, assuming confirmation of persistent elevation through a second reading.

SMM 20 by Race and EthnicityMonthly up to 2 years

Severe maternal morbidity (SMM) by Race and Ethnicity includes unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health. Based on 20 ICD 10 codes as defined by the CDC.

Process Measure for Severe Hypertension/Preeclampsia - Nursing EducationMonthly up to 6 months

Report estimate in 10 percent increments (round up) At the end of this reporting period, what cumulative proportion of OB nurses (including L\&D and postpartum) has completed within the last two years an education program on Severe Hypertension/Preeclampsia that includes the unit-standard protocols and measures?

Process Measure for Obstetric Hemorrhage - Unit DrillsMonthly up to 6 months

Report number of Drills and the drill topics P1a: In this quarter, how many OB drills (In Situ and/or Sim Lab) were performed on your unit for any maternal safety topic? P1b: In this quarter, what topics were covered in the OB drills?

Structure Measure for Obstetric Hemorrhage - Multidisciplinary Case ReviewsMonthly up to 6 months

Report Start Date Has your hospital established a process to perform multidisciplinary systems-level reviews on cases of severe maternal morbidity (including, at a minimum, birthing patients admitted to the ICU or receiving ≥ 4 units RBC transfusions?

SMM 21 by Race and EthnicityMonthly up to 2 years

Severe maternal morbidity (SMM) by Race and Ethnicity includes unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health. Based on 21 ICD 10 codes as defined by the CDC.

Process Measure for Severe Hypertension/Preeclampsia - Unit DrillsMonthly up to 6 months

Report number of Drills and the drill topics P1a: In this quarter, how many OB drills (In Situ and/or Sim Lab) were performed on your unit for any maternal safety topic? P1b: In this quarter, what topics were covered in the OB drills?

Process Measure for Severe Hypertension/Preeclampsia - Provider EducationMonthly up to 6 months

Report estimate in 10 percent increments (round up) At the end of this reporting period, what cumulative proportion of delivering physicians and midwives has completed within the last two years an education program on Severe Hypertension/Preeclampsia that includes the unit-standard protocols and measures?

Process Measure for Obstetric Hemorrhage - Provider EducationMonthly up to 6 months

Report estimate in 10 percent increments (round up) At the end of this reporting period, what cumulative proportion of delivering physicians and midwives has completed within the last 2 years an education program on Obstetric Hemorrhage that includes the unit-standard protocols and measures?

Structure Measure for Obstetric Hemorrhage - Debriefs SystemMonthly up to 6 months

Report Start Date Has your hospital established a system in your hospital to perform regular formal debriefs after cases with major complications?

Process Measure for Obstetric Hemorrhage - Nursing EducationMonthly up to 6 months

Report estimate in 10 percent increments (round up) At the end of this reporting period, what cumulative proportion of OB nurses (including L\&D and Postpartum) has completed within the last 2 years an education program on Obstetric Hemorrhage that includes the unit-standard protocols and measures?

Outcome Measure for Severe Hypertension/Preeclampsia - Severe Maternal Morbidity (excluding transfusion codes) among Preeclampsia CasesMonthly up to 6 months

Denominator: All mothers during their birth admission, excluding ectopics and miscarriages, with one of the following diagnosis codes:

* Severe Preeclampsia

* Eclampsia

* Preeclampsia superimposed on pre-existing hypertension Numerator: Among the denominator, all cases with any non-transfusion SMM code

Trial Locations

Locations (1)

Tufts University

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath